Wockhardt Limited WOCKPHARMA.NS · Stock Open Wockhardt Limited in new tab
Wockhardt Limited Analysis (WOCKPHARMA.NS)
Is Wockhardt Limited a good investment? Wockhardt Limited (WOCKPHARMA.NS) is currently trading at 2083.90 INR.
In terms of valuation, the stock trades at a P/E ratio of 83.88. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Wockhardt Limited is expected to release its next earnings report on May 27, 2026.
Investor FAQ
Does Wockhardt Limited pay a dividend?
No, it does not currently pay a dividend.
What asset class is Wockhardt Limited?
Wockhardt Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be May 27, 2026. The company currently has a trailing EPS of 25.23.
Company Profile
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine, as well as offers insulin aspart regular and biphasic drug products. Further, the company offers delivery devices for insulin, including DispoPen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
| Year | Total Dividends |
|---|---|
| ▸2016 |
10.00 INR
|
| Nov. 25, 2016 | 10.0000 |
| ▸2014 |
25.00 INR
|
| Dec. 2, 2014 | 20.0000 |
| March 11, 2014 | 5.0000 |
| ▸2013 |
10.00 INR
|
| Nov. 24, 2013 | 5.0000 |
| Oct. 2, 2013 | 5.0000 |
| ▸2008 |
2.50 INR
|
| June 1, 2008 | 2.5000 |
| ▸2007 |
13.75 INR
|
| Dec. 1, 2007 | 8.7500 |
| April 1, 2007 | 5.0000 |
| ▸2006 |
5.00 INR
|
| July 8, 2006 | 5.0000 |
| ▸2005 |
5.00 INR
|
| April 29, 2005 | 5.0000 |
| ▸2004 |
7.50 INR
|
| May 22, 2004 | 7.5000 |
| ▸2003 |
6.50 INR
|
| June 20, 2003 | 6.5000 |
Community Discussion